Belimumab combined with SOC was successful for inducing remission among patients with SLE, including those with LN.

A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

The 25th November is marked by the United Nations as the International Day for the Elimination of Violence against Women. Violence against women and girls is a devastating and fundamental violation of ...